These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4909462)

  • 21. Bioavailability of peroral dosage forms.
    Ritschel WA
    Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of bioavailabilities and dissolution characteristics of commercial tablet formulations of sulfamethizole.
    Mattok GL; McGilveray IJ
    J Pharm Sci; 1972 May; 61(5):746-9. PubMed ID: 5035783
    [No Abstract]   [Full Text] [Related]  

  • 23. Multi-unit dosage formulations of theophylline for controlled release applications.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of surface lubrication: influence of duration of lubricant-excipient mixing on processing characteristics of powders and properties of compressed tablets.
    Shah AC; Mlodozeniec AR
    J Pharm Sci; 1977 Oct; 66(10):1377-8. PubMed ID: 925889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustaining pattern of phenformin hydrochloride using various polymers and waxes.
    Pandey VP; Kannappan N; Manavalan R; Subburaj T
    Boll Chim Farm; 2002; 141(5):361-6. PubMed ID: 12481378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preformulation studies in a drug development program for tablet formulations.
    Graffner C; Johansson ME; Nicklasson M; Nyqvist H
    J Pharm Sci; 1985 Jan; 74(1):16-20. PubMed ID: 3981410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of drug release from acetaminophen granules by melt granulation technique - consideration of release kinetics.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2006 Jan; 19(1):22-7. PubMed ID: 16632448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of enteric-coated microcapsules for tableting by spray-drying technique and in vitro simulation of drug release from the tablet in GI tract.
    Takenaka H; Kawashima Y; Lin SY
    J Pharm Sci; 1980 Dec; 69(12):1388-92. PubMed ID: 7463321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New oral solid dosage form for furosemide oral administration.
    Perioli L; D'Alba G; Pagano C
    Eur J Pharm Biopharm; 2012 Apr; 80(3):621-9. PubMed ID: 22230797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mathematical model considering change of diffusion coefficient for predicting dissolution behavior of acetaminophen from wax matrix dosage form.
    Nitanai Y; Agata Y; Iwao Y; Itai S
    Int J Pharm; 2012 May; 428(1-2):82-90. PubMed ID: 22405986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
    Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
    Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biopharmaceutics of drugs. Application to three tablet formulations of acetylsalicylic acid].
    Cid E; Moran I
    J Pharm Belg; 1975; 30(3):279-91. PubMed ID: 1206460
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of action of starch as a tablet disintegrant. II. Effect of pepsin and surfactants on swelling of starch grains at 37 degrees.
    Ingram JT; Lowenthal W
    J Pharm Sci; 1968 Jan; 57(1):187-8. PubMed ID: 4870848
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral dosage form design and its influence on dissolution rates for a series of drugs.
    Hom FS; Miskel JJ
    J Pharm Sci; 1970 Jun; 59(6):827-30. PubMed ID: 4192950
    [No Abstract]   [Full Text] [Related]  

  • 37. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives.
    Breda SA; Jimenez-Kairuz AF; Manzo RH; Olivera ME
    Int J Pharm; 2009 Apr; 371(1-2):106-13. PubMed ID: 19150493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of a drug from a dosage form.
    Stelmach H; Robinson JR; Eriksen SP
    J Pharm Sci; 1965 Oct; 54(10):1453-8. PubMed ID: 5899123
    [No Abstract]   [Full Text] [Related]  

  • 39. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release from or through a wax matrix system. I. Basic release properties of the wax matrix system.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1448-51. PubMed ID: 11724236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.